Jahan Marcu, Ph.D., has over 15 years of experience in academic research, industry, and government relations. Dr. Marcu is presently the Chief Operations Officer, Director of Experimental Pharmacology and Behavioral Research at International Research Center on Cannabis and Mental Health (IRCCMH), which he co-founded. Dr. Marcu is the former Chief Science Officer at Americans for Safe Access (a medical cannabis advocacy non-profit) and former Director of the Patient Focused Certification program, which is a health and safety oversight program that assesses regulatory compliance at cannabis operations. Dr. Marcu published the first direct measurements of THC and CBD synergy, for which he received the Billy Martin research award from the International Cannabinoid Research Society. His Ph.D focused on solving the structure and function of the CB1 receptor as well as investigating the role of the endocannabinoid system in bone.
He is co-founder and past-chairman of the CANN subdivision of the Chemical Health and Safety Division (DCHAS) ofthe American Chemical Society. Dr. Marcu helped start the International Cannabis and Cannabinoid Institute (ICCI), helping design and propose their initial research projects such as the metabolomic data library for cannabis varieties, raising $20 million dollars for ICCI. His also served on the Board of Directors of the International Association for Cannabinoids as Medicine (IACM). He has a background in analytical chemistry and molecular pharmacology, he received his Ph.D. for contributions in characterizing the structure and function of the cannabinoid receptors. He is an author of the American Herbal Pharmacopeia’s Cannabis Monograph and serves on multiple expert government, trade association committees, scientific organizations and is a court-qualified synthetic cannabinoid and cannabis expert. He is also a chairman of ASTM’s D37 Cannabis committee, which is developing the international standards for the cannabis industry.
Dr. Marcu has helped create medical cannabis educational training for clinicians and for workers in the medical cannabis industry, and has been invited to speak at many international conferences and universities, including the University of Leiden, Temple University School of Medicine, Princeton Hospital, and Yale University. Dr. Marcu is also a court qualified expert witness on cannabis and synthetic cannabinoids. And he is consultant to state regulators, helping to develop cannabis regulations and train state inspectors for various operations.